Notify me when Tikvah Management LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 23 | $331M | +$8.05M | -$35.4M | -$27.4M | AMZN, GOOGL, CMPO, BIO, SPY | 13F-HR | 14 Nov 2025, 12:38 |
| Q2 2025 | 22 | $303M | +$956K | -$22.5M | -$21.6M | AMZN, GOOGL, CMPO, BIO, SPY | 13F-HR | 13 Aug 2025, 18:16 |
| Q1 2025 | 24 | $288M | +$12M | -$14.2M | -$2.28M | AMZN, GOOGL, BIO, CMPO, SPY | 13F-HR | 13 May 2025, 14:26 |
| Q4 2024 | 24 | $367M | +$14.4M | -$6.27M | +$8.12M | AMZN, GOOGL, BIO, CMPO, PCOR | 13F-HR | 12 Feb 2025, 17:52 |
| Q3 2024 | 24 | $323M | +$986K | -$11.2M | -$10.2M | AMZN, BIO, GOOGL, CMPO, SPY | 13F-HR | 12 Nov 2024, 12:23 |
| Q2 2024 | 25 | $283M | +$7.03M | -$2.16M | +$4.87M | AMZN, GOOGL, BIO, PCOR, GOOG | 13F-HR | 12 Aug 2024, 13:13 |
| Q1 2024 | 22 | $318M | +$25.3M | -$20.7M | +$4.59M | AMZN, BIO, GOOGL, PCOR, SPY | 13F-HR | 14 May 2024, 17:32 |
| Q4 2023 | 22 | $291M | +$19.2M | -$24.8M | -$5.61M | AMZN, BIO, GOOGL, PCOR, AVDX | 13F-HR | 13 Feb 2024, 18:29 |
| Q3 2023 | 22 | $279M | +$1.02M | -$7.49M | -$6.47M | AMZN, BIO, GOOGL, AVDX, PCOR | 13F-HR | 13 Nov 2023, 18:36 |
| Q2 2023 | 22 | $294M | +$30.7M | -$2.39M | +$28.3M | AMZN, BIO, GOOGL, AVDX, PCOR | 13F-HR | 11 Aug 2023, 14:41 |
| Q1 2023 | 23 | $243M | +$12.6M | +$12.6M | BIO, AMZN, GOOGL, AVDX, PCOR | 13F-HR | 10 May 2023, 11:28 | |
| Q4 2022 | 23 | $209M | +$13.6M | -$3.94M | +$9.64M | BIO, AMZN, AVDX, GOOGL, SPY | 13F-HR | 06 Feb 2023, 13:47 |
| Q3 2022 | 23 | $216M | +$38.5M | +$38.5M | AMZN, BIO, GOOGL, AVDX, SPY | 13F-HR | 14 Nov 2022, 12:04 | |
| Q2 2022 | 24 | $232M | +$45M | -$399K | +$44.6M | BIO, AMZN, GOOGL, AVDX, SPY | 13F-HR | 12 Aug 2022, 17:56 |
| Q1 2022 | 23 | $313M | +$80.7M | +$80.7M | AMZN, BIO, GOOGL, AVDX, SLGC | 13F-HR | 16 May 2022, 14:13 | |
| Q4 2021 | 21 | $357M | +$72.7M | -$1.01M | +$71.7M | BIOB, AMZN, GOOGL, AVDX, SPY | 13F-HR | 14 Feb 2022, 09:46 |
| Q3 2021 | 21 | $370M | +$45.8M | -$50.5M | -$4.69M | BIOB, AMZN, INOV, GOOGL, SMRT | 13F-HR | 12 Nov 2021, 11:30 |
| Q2 2021 | 18 | $362M | +$83M | -$125M | -$42M | AMZN, BIOB, QADA, INOV, GOOGL | 13F-HR | 13 Aug 2021, 17:40 |
| Q1 2021 | 16 | $357M | +$1.64M | -$25.2M | -$23.6M | BIO, QADA, AMZN, INOV, GOOGL | 13F-HR | 14 May 2021, 17:36 |
| Q4 2020 | 17 | $359M | +$3.15M | -$8.54M | -$5.4M | BIO, AMZN, QADA, INOV, GOOGL | 13F-HR | 16 Feb 2021, 20:39 |
| Q3 2020 | 17 | $324M | +$2.76M | -$26.7M | -$23.9M | BIO, AMZN, QADA, INOV, FARO | 13F-HR | 16 Nov 2020, 16:03 |
| Q2 2020 | 19 | $327M | +$15.7M | +$15.7M | AMZN, BIO, QADA, INOV, FARO | 13F-HR | 14 Aug 2020, 09:00 | |
| Q1 2020 | 17 | $253M | +$2.19M | -$73M | -$70.8M | AMZN, BIO, QADA, INOV, FARO | 13F-HR | 14 May 2020, 17:54 |
| Q4 2019 | 18 | $387M | +$3.68M | +$3.68M | BIO, QADA, AMZN, INOV, GOOG | 13F-HR | 13 Feb 2020, 12:23 | |
| Q3 2019 | 19 | $359M | +$9.58M | -$4.64M | +$4.94M | BIO, QADA, AMZN, INOV, GOOG | 13F-HR | 13 Nov 2019, 12:57 |
| Q2 2019 | 19 | $352M | +$42M | +$42M | AMZN, BIO, QADA, FARO, INOV | 13F-HR | 13 Aug 2019, 09:40 | |
| Q1 2019 | 19 | $301M | +$8.51M | -$1.24M | +$7.27M | AMZN, BIO, QADA, INOV, FARO | 13F-HR | 14 May 2019, 15:52 |
| Q4 2018 | 20 | $282M | +$27.2M | -$8.58M | +$18.6M | AMZN, QADA, BIO, INOV, NATI | 13F-HR | 13 Feb 2019, 12:38 |
| Q3 2018 | 19 | $335M | +$5.86M | -$16.2M | -$10.3M | QADA, AMZN, BIO, NATI, FARO | 13F-HR | 13 Nov 2018, 15:30 |
| Q2 2018 | 18 | $319M | -$20M | -$20M | QADA, AMZN, BIO, NATI, FARO | 13F-HR | 14 Aug 2018, 12:16 | |
| Q1 2018 | 18 | $325M | +$61.4M | +$61.4M | AMZN, QADA, BIO, INDA, NATI | 13F-HR | 14 May 2018, 18:39 | |
| Q4 2017 | 18 | $249M | +$1.82M | -$3.85M | -$2.03M | QADA, BIO, AMZN, NATI, BRKA | 13F-HR | 13 Feb 2018, 17:15 |
| Q3 2017 | 19 | $236M | +$15.3M | +$15.3M | QADA, BIO, AMZN, NATI, INOV | 13F-HR | 13 Nov 2017, 18:11 | |
| Q2 2017 | 18 | $212M | +$3.99M | -$1.94K | +$3.99M | QADA, BIO, AMZN, NATI, BRKA | 13F-HR | 11 Aug 2017, 18:01 |
| Q1 2017 | 17 | $191M | +$10.3M | -$15.5M | -$5.15M | BIO, QADA, AMZN, BRKA, NATI | 13F-HR | 12 May 2017, 13:12 |
| Q4 2016 | 18 | $203M | +$6.11M | -$7.71M | -$1.6M | QADA, BIO, SPY, AMZN, BRKA | 13F-HR | 13 Feb 2017, 10:35 |
| Q3 2016 | 18 | $192M | +$18.7M | +$18.7M | QADA, BIO, AMZN, SPY, NATI | 13F-HR | 14 Nov 2016, 08:44 | |
| Q2 2016 | 17 | $171M | +$2.31M | -$7.94K | +$2.3M | SPY, QADA, BIO, AMZN, NATI | 13F-HR | 15 Aug 2016, 11:04 |
| Q1 2016 | 16 | $180M | +$12.7M | -$6.07M | +$6.67M | QADA, SPY, NATI, BIO, AMZN | 13F-HR | 16 May 2016, 11:12 |
| Q4 2015 | 18 | $191M | +$32.9M | +$32.9M | SPY, QADA, NATI, BIO, AMZN | 13F-HR | 16 Feb 2016, 09:57 | |
| Q3 2015 | 19 | $180M | +$2.86M | -$4.62M | -$1.75M | QADA, SPY, NATI, BIO, AMZN | 13F-HR | 16 Nov 2015, 08:58 |
| Q2 2015 | 19 | $189M | +$7.07M | -$4.89M | +$2.18M | SPY, QADA, NATI, BIO, NICE | 13F-HR | 14 Aug 2015, 10:57 |
| Q1 2015 | 19 | $181M | +$35.1M | -$6.72M | +$28.4M | SPY, QADA, NATI, BRKA, NICE | 13F-HR | 15 May 2015, 11:00 |
| Q4 2014 | 16 | $153M | +$16M | -$224K | +$15.8M | SPY, BRKA, NATI, NICE, BIO | 13F-HR | 17 Feb 2015, 09:06 |
| Q3 2014 | 16 | $131M | +$939K | -$159K | +$780K | SPY, BRKA, NATI, BAC, GS | Restatement | 21 Nov 2014, 08:43 |
| Q2 2014 | 17 | $142M | +$21.5M | -$54.2K | +$21.4M | SPY, NATI, BRKA, BIOB, NICE | 13F-HR | 14 Aug 2014, 11:03 |
| Q1 2014 | 17 | $135M | SPY, BRKA, BIO, NATI, BAC | 13F-HR | 15 May 2014, 11:00 |